Mary Ann Liebert: Implementing Post-Genomic Personalized Medicine - The Rise of Glycan Biomarkers
January 14, 2020
January 14, 2020
NEW ROCHELLE, New York, Jan. 14 -- Mary Ann Liebert Inc. issued the following news release:
An in-depth look at the science of glycobiology and glycan diagnostics, and their promise in personalized medicine in the current post-genomic era are featured in a special issue of OMICS: A Journal of Integrative Biology, the peer-reviewed interdisciplinary journal published by Mary Ann Liebert, Inc., publishers. Click here (http://click.liebertpubmail.com/?qs=e604fb0041fd64d5a1396f8458cbcd9 . . .
An in-depth look at the science of glycobiology and glycan diagnostics, and their promise in personalized medicine in the current post-genomic era are featured in a special issue of OMICS: A Journal of Integrative Biology, the peer-reviewed interdisciplinary journal published by Mary Ann Liebert, Inc., publishers. Click here (http://click.liebertpubmail.com/?qs=e604fb0041fd64d5a1396f8458cbcd9 . . .